Publication

Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting

Journal Paper/Review - Mar 21, 2009

Brändle Michael, Goodall G, Erny-Albrecht K M, Erdmann E, Valentine W J